40 postmenopausal women, with a non-operated proximal humeral fracture, will be randomized to standard treatment (physiotherapy) or standard treatment + Forsteo (rhPTH 1-34) during 4 weeks. Follow-up will be at 7 weeks and 3 months including x-ray and DASH score (The Disabilities of the Arm, Shoulder and Hand) measuring physical function, and pain on a visual analoge scale (VAS). Two doctors, blinded to the treatment, will judge the callus formation and healing on the x-rays and guess the treatment. The DASH score and the pain score will be compared between the treatment groups. The investigators hypotheses are that callus formation and healing will be more pronounced and that patients have less pain and better function in the rhPTH 1-34 group.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
40
Teriparatide (Forsteo) 20 micrograms daily during four weeks
Lasarettet i Motala
Motala, Sweden
Department of Orthopaedics
Norrköping, Sweden
Callus formation and fracture healing at 7 weeks judged by a blinded assessor who will guess the treatment
Time frame: 7 weeks
Function
The function in the upper extremity will be measured using DASH. The experimental group will be compared with the control group
Time frame: 7 weeks and 3 months
Pain
Pain at rest and during activity will be measured using a visual analogue scale (VAS). The experimental group will be compared with the control group
Time frame: 7 weeks and 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.